Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Bulletin Du Cancer|August 6, 2009
[Confidentiality in medical practice: tell no one]Sébastien Couraud, Dominique Arpin, Maurice Perol, et al.
Cancer Research|June 19, 2007
Patterns of EGFR, HER2, TP53, and KRAS mutations of p14arf expression in non-small cell lung cancers in relation to smoking historyMounia Mounawar, Anush Mukeria, Florence Le Calvez, et al.
Radiology|November 16, 2021
Dual-Energy CT Perfusion of Invasive Tumor Front in Non-Small Cell Lung CancersJulie Dewaguet, Marie-Christine Copin, Alain Duhamel, et al.
Nutrients|March 28, 2024
Daily Caffeine Consumption May Increase the Risk of Acute Kidney Injury Related to Platinum-Salt Chemotherapy in Thoracic Cancer Patients: A Translational StudyAghiles Hamroun, Antoine Decaestecker, Romain Larrue, et al.
Diagnostic and Interventional Imaging|March 2, 2021
Intergroupe francophone de cancérologie thoracique, Société de pneumologie de langue française, and Société d'imagerie thoracique statement paper on lung cancer screeningSébastien Couraud, Gilbert Ferretti, Bernard Milleron, et al.
Targeted Oncology|June 13, 2023
Real-World Treatment Outcomes of MET Exon14 Skipping in Non-small Cell Lung Cancer: GFPC 03-18 StudyHélène Babey, Philippe Jamme, Hubert Curcio, et al.
Journal of Thoracic Imaging|July 13, 2015
Imaging Tumor Response and Tumoral Heterogeneity in Non-Small Cell Lung Cancer Treated With Antiangiogenic Therapy: Comparison of the Prognostic Ability of RECIST 1.1, an Alternate Method (Crabb), and Image Heterogeneity AnalysisConnie Yip, Nunzia Tacelli, Martine Remy-Jardin, et al.
Lung Cancer (Amsterdam, Netherlands)|September 7, 2019
Brigatinib in patients with ALK-positive advanced non-small-cell lung cancer pretreated with sequential ALK inhibitors: A multicentric real-world study (BRIGALK study)Renaud Descourt, Maurice Perol, Gaëlle Rousseau-Bussac, et al.
NEJM Evidence|June 24, 2025
Survival of Patients with Lung Adenocarcinoma Diagnosed in 2000, 2010, and 2020Didier Debieuvre, Lionel Falchero, Olivier Molinier, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 28, 2018
c-MET Overexpression as a Poor Predictor of MET Amplifications or Exon 14 Mutations in Lung Sarcomatoid CarcinomasXavier Mignard, Anne-Marie Ruppert, Martine Antoine, et al.
Pageof 5